EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSELUG00000006209
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

26s Protease Regulatory Subunit 10b-Like

Ensembl ID : ENSELUG00000008779
Gene Symbol: LOC105017573
3 Cross references
241 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSELUG00000008204
Gene Symbol: LOC105007394
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSELUG00000009051
Gene Symbol: LOC105008611
3 Cross references
228 Possible Orthologues:

26s Proteasome Regulatory Subunit 4

Ensembl ID : ENSELUG00000007596
Gene Symbol: LOC105017692
2 Cross references
307 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSELUG00000006676
Gene Symbol: HMGCR
3 Cross references
194 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase

Ensembl ID : ENSELUG00000007320
Gene Symbol: LOC105015131
3 Cross references
206 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2

Ensembl ID : ENSELUG00000016118
Gene Symbol: LOC105031435
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSELUG00000010174
Gene Symbol: PDPK1
3 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSELUG00000022705
Gene Symbol: LOC105024848
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S23

Ensembl ID : ENSELUG00000020180
Gene Symbol: LOC105017455
3 Cross references
367 Possible Orthologues:

40s Ribosomal Protein S23

Ensembl ID : ENSELUG00000025078
Gene Symbol: LOC105013954
3 Cross references
370 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).